Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track)

Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02395380

Acronym

CRP-Track

Enrollment

174

Registered

2015-03-23

Start date

2015-07-06

Completion date

2017-06-13

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Postoperative Complication

Keywords

CRP, Postoperative complication, Length of stay

Brief summary

Colic and rectal resection represents a majority of hospitalizations in visceral surgery. The objective of this study was to evaluate the prognostic of inflammatory markers dosage (CRP, procalcitonin and venous lactate) on the postoperative recovery after colorectal surgery and on the length of stay.

Interventions

OTHERC-reactive protein dosage

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Upper age to 18 years * Planned hospital stay for a colonic resection with anastomosis without permanent or temporary digestive bypass * Patient with pre-operative CRP lower or egal to 172 mg/L * No opposition at the participation of the study * Expected patient return home after surgery (or convalescent home or not medicalized institution)

Exclusion criteria

* Patient under guardianship * Protected or private patient freedom * Minor patient * Colectomy surgery with digestive bypass or digestive anastomosis * Complex combined surgery (significantly intestinal resection associated, another surgical procedure that can interfere with postoperative CRP) * General inflammatory disease susceptive to modify dosage values * Anti-inflammatory therapy (AINS/ corticosteroids/ immunosuppressive) * Patient unable to understand the study

Design outcomes

Primary

Measure	Time frame	Description
C-reactive Protein Rate	5 postoperative days	Comparison C-reactive protein levels \< 172 mg/l at 3 post operative day with composite endpoint postoperative recovery (fever, absence of pain \>2, intestinal gas transit and patient autonomy for mobility and body care) at 5 post operative day. The Specificity, Sensitivity, PPV, NPV of C-Reactive Protein Levels at Day 3 Post-operative in Determining Day 5 Post-operative Recovery

Countries

France

Contacts

STUDY_DIRECTOREmeric ABET

Centre Hospitalier Departemental Vendee

Participant flow

Pre-assignment details

Of 174 enrolled participants, 168 met inclusion criteria

Baseline characteristics

Characteristic	—
Age, Continuous	65.1 years STANDARD_DEVIATION 13.2
Sex: Female, Male Female	76 Participants
Sex: Female, Male Male	92 Participants

Adverse events

Event type	EG000 affected / at risk
deaths Total, all-cause mortality	1 / 168
other Total, other adverse events	0 / 168
serious Total, serious adverse events	0 / 168

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 21, 2026